Trials for Orocidin are planned at the University of Copenhagen, following Bio-Convert receiving a toxicity waiver from the Danish Medicines Agency.
1 report, 1 independent
Updated Jun 1
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Trials for Orocidin are planned at the University of Copenhagen, following Bio-Convert receiving a toxicity waiver from the Danish Medicines Agency.
Who's involved
What this event is mainly aboutUniversity of CopenhagenDanish Medicines Agency
Keep exploring
The entities involved
-
University of Copenhagen
public research university in Copenhagen, Denmark